The Elderly Patient with Cardiovascular Disease

Heart Disease

Volumn 2, Issue 1, 2000, Pages 31-61

  Wenger, Nanette Kass ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; AGED; AGING; CARDIOVASCULAR DISEASE; HUMAN; PHYSIOLOGY; REVIEW;

AGE FACTORS; AGED; AGING; CARDIOVASCULAR DISEASES; HUMAN;

EID: 0033762409     PISSN: 1521737X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (293)

1. National Center for Health Statistics. Advance report of final mortality statistics, 1988. Monthly Vital Statistics Report 1990;39(suppl):1-48.
2. Wenger NK, ed. Cardiovascular Disease in the Octogenarian and Beyond. London: Martin Dunitz, 1999.
3. Manton KG. Changing concepts of morbidity and mortality in the elderly population. Milbank Mem Fund Q 1982;60:183-244.
4. Mittelmark MB, Psaty BM, Rautaharju PM, Fried LP, Borhani NO, Tracy RP, et al. Prevalence of cardiovascular diseases among older adults: the Cardiovascular Health Study. Am J Epidemiol 1993;137:311-317.
5. Sollott SJ, Lakatta EG. Normal aging changes in the cardiovascular system. Cardiol Elderly 1993;1:349-358.
6. Lernfelt B, Wikstrand I, Svanborg A, Landahl S. Aging and left ventricular function in elderly healthy people. Am J Cardiol 1991;68:547-549.
7. Ghali JK, Liao Y, Cooper RS, Cao G. Changes in pulmonary hemodynamics with aging in a predominantly hypertensive population. Am J Cardiol 1992; 70:367-370.
8. 2 max. J Appl Pbysiol 1988;65:1147-1151.
9. Olivetti G, Giordano G, Corradi D, Melissari M, Lagrasta C, Gambert SR, Anversa P. Gender differences and aging: effects on the human heart. J Am Coll Cardiol 1995;26:1068-1079.
10. Bennet NE. Hypertension in the elderly. Lancet 344:447-449.
11. Mader SL, Josephson KR, Rubenstein LZ. Low prevalence of postural hypotension among community-dwelling elderly. JAMA 1987;258:1511-1515.
12. Vaitkevicius PV, Essenvein DM, Maynard AK, O'Connor FC, Kleg JL. Frequency and importance of postprandial blood pressure reduction in elderly nursing-home patients. Ann Intern Med 1991;115:865-870.
13. Ooi WL, Barret S, Hossain M, Kelley-Gagnon M, Lipsitz IA. Patterns of orthostatic blood pressure change and their clinical correlates in a frail, elderly population. JAMA 1997;277:1299-1304.
14. Jansen RWMM, Connclly CM, Kelley-Gagnon MM, Parker JA, Lipsitz LA. Postprandial hypotension in elderly patients with unexplained syncope. Arch Intern Med 1995;155:945-952.
15. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS, for the CHS Collaborative Research Group. Orthostatic hypotension in older adults: the Cardiovascular Health Study. Hypertension 1992;19(part I):508-519.
16. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, Wolfson SK, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Circulation 1993;88:837-845.
17. Tsuji H, Venditti FJ Jr, Manders ES, Kvans JC, Larson MG, Feldman CL, Levy DL. Reduced heart rate variability and mortality risk in an elderly cohort: the Framingham Heart Study. Circulation 1994;90:878-883.
18. Rautaharju PM, Manolio TA, Psaty BM, Borhani NO, Farberg CD, tor the Cardiovascular Health Study Collaborative Research Group. Correlates of QT prolongation in older adults (the Cardiovascular Health Study). Am J Cardiol 1994;73:999-1002.
19. Furberg CD, Manolio TA, Psaty BM, Bild DE, Borhani NO, Newman A, et al, for the Cardovascular Health Study Collaborative Research Group. Major electrocardiographic abnormalities in persons aged 65 years and older: the Cardiovascular Health Study. Am J Cardiol 1992;69:1329-1335.
20. Kahn S, Frishman WH, Weissman S, Ooi WL, Aronson M. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects. A report from the Bronx Longitudinal Aging Study. J Am Geriatr Soc 1996;44:524-529.
21. Bharati S, Lev M. Pathologic changes of the conduction system with aging. Cardiol Elderly 1994;2:152-160.
22. Deckers JW, Simoons ML, Fioretti P. The value of exercise testing in elderly patients. Geriatr Cardiovasc Med 1988;1:89-93.
23. Iskandrian AS, Heo J, Decoskey D, Askenase A, Segal BL. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease. Am J Cardiol 1988;61:269-272.
24. Hilton TC, Shaw LJ, Chaitman BR, Stocke KS, Goodgold HM, Miller DD. Prognostic significance of exercise thallium-201 testing in patients aged ≥70 years with known or suspected coronary artery disease. Am J Cardiol 1992;69: 45-50.
25. Gerson MC, Moore EN, Ellis K. Systemic effects and safety of intravenous dipyridamole in elderly patients with suspected coronary artery disease. Am J Cardiol 1987;60:1399-1401.
26. Lam JYT, Chaitman BR, Glaenzer M. Safety and diagnostic accuracy of dipyridamole-thallium imaging in the elderly. J Am Coll Cardiol 1988;11:585-589.
27. Gersh BJ, Kronmal RA, Frye RL, Schaff HV, Ryan TJ, Gosselin AJ, et al. Coronary arteriography and coronary artery bypass surgery: morbidity and mortality in patients ages 65 years or older. A report from the Coronary Artery Surgery Study. Circulation 1983;67:483-491.
28. Clark VL, Khaja F. Risk of cardiac catheterization in patients aged ≥80 years without previous cardiac surgery. Am J Cardiol 1994;74:1076-1077.
29. Bild DE, Fitzpatrick A, Fried LP, Wong ND, Haan MN, Lyles M, et al. Age-related trends in cardiovascular morbidity and physical functioning in the elderly: the Cardiovascular Health Study. J Am Geriatr Soc 1993;41:1047-1056.
30. Corti M-C, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 1996;49:519-526.
31. Dawson DA, Adams PF. Current estimates from the National Health Interview Survey, United States, 1986. Vital and Health Statistics. Series 10, no. 164. Department of Health and Human Services Publication PHS 87-1592. Hyattsville, MD: National Center for Health Statistics, Public Health Service, 1987:98.
32. Graves EJ. 1989 National Hospital Discharge Survey. Advance data from vital and health statistics no. 199 (summary). Hyattsville, MD: National Center for Health Statistics, 1991;1-12.
33. Marcus FI, Friday K, McCans J, Moon T, Hahn E, Cobb L, et al. Age-related prognosis after acute myocardial infarction: the Multiccnter Diltiazem Postinfarction trial. Am J Cardiol 1990;65:559-566.
34. Pashos CL, Newhouse JP, McNeil BJ. Temporal changes in the care and outcomes of elderly patients with acute myocardial infarction, 1987 through 1990. JAMA 1993;270:1832-1836.
35. American Heart Association National Center. Vital Statistics of the United States. Dallas, TX: American Heart Association, 1995.
36. LaCroix AZ, Guralnik JM, Curb JD, Wallace RB, Ostfeld AM, Hennekens CH. Chest pain and coronary heart disease mortality among older men and women in three communities. Circulation 1990;81:437-446.
37. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E, for the TIDES Investigators. Characterisrics of a contemporary population with angina pectons. Am J Cardiol 1994;74:226-231.
38. Stone PH, Thompson H, Anderson HV, Kronenberg MW, Gibson RS, Rogers WJ, et al, for the TIMI III Registry Study Group. Influence of race, sex, and age on management of unstable angina and non-Q-wave myocardial infarction: the TIMI III Registry. JAMA 1996;275:1104-1112.
39. Umachandran V, Ranjadayalan K, Ambepityia G, Marchant B, Kopelman PG, Timmis AD, Aging, autonomic function, and the perception of angina. Br Heart J 1991;66:15-18.
40. Nadelmann J, Frishman WH, Ooi WL, Tepper D, Greenberg S, Guzik H, et al. Prevalence, incidence and prognosis of recognized and unrecognized myocardial infarction in persons aged 75 years or older: the Bronx Aging Study. Am J Cardiol 1990;66:533-537.
41. Solomon CG, Lee TH, Cook EF, Weisberg MC, Brand DA, Rouan GW, Goldman L, for the Chest Pain Study Group. Comparison of clinical presentation of acute myocardial infarction in patients older than 65 years of age to younger patients: the Multicenter Chest Pain Study experience. Am J Cardiol 1989;63:772-776.
42. Svanborg A, Bergstrom G, Mellstrom D. Epidemiological studies on social and medical conditions of the elderly. European Reports and Studies 62. Copenhagen: WHO Regional Office for Europe, 1982.
43. Gurwitz JH, McLaughlin TJ, Willison DJ, Guadagnoli E, Hauptman PJ, Gao X, Soumerai SB. Delayed hospital presentation in patients who have had acute myocardial infarction. Ann Intern Med 1997;126:593-599.
44. Hong RA, Licht JD, Wei JY, Heller GV, Blaustein AS, Pasternak RC. Elevated CK-MB with normal total creatine kinase in suspected myocardial infarction: associated clinical findings and early prognosis. Am Heart J 1986;111:1041-1047.
45. Paul SD, O'Gara PT, Mahjoub ZA, DiSalvo TG, O'Donnell CJ, Newell JB, et al. Geriatric patients with acute myocardial infarction: cardiac risk factor profiles, presentation, thrombolysis, coronary interventions, and prognosis. Am Heart J 1996;131:710-715.
46. Devlin W, Cragg D, Jacks M, Friedman H, O'Neill W, Grines C. Comparison of outcome in patients with acute myocardial infarction aged >75 years with that in younger patients. Am J Cardiol 1995;75:573-576.
47. Krumholz HM, Murillo JE, Chen J, Vaccarino V, Radford MJ, Ellerbeck EF, Wang Y. Thrombolytic therapy tor eligible elderly patients with acute myocardial infarction. JAMA 1997;277:1683-1688.
48. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Micardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
49. Weaver WD, Litwin PH, Martin JS, Kudenchuk PJ, Maynard C, Eisenberg MS, et al, for the MITI Project Group. Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction. J Am Coll Cardiol 1991;18:657-662.
50. Bueno H, López-Palop R, Bermejo J, López-Sendón JL, Delcán JL. In-hospital outcome of elderly patients with acute inferior myocardial infarction and right ventricular involvement. Circulation 1997;96:436-441.
51. McClellan M, McNeil BJ, Newhouse JP. Does more intensive treatment of acute myocardial infarction in the elderly reduce mortality? Analysis using instrumental variables. JAMA 1994;272:859-866.
52. Gottlieb S, Goldbourt U, Boyko V, Barbash G, Mandelzweig L, Reicher-Reiss H, et al. for the SPRINT and Thrombolytic Survey Groups. Improved outcome of elderly patients (>75 years of age) with acute myocardial infarction 1981-1983 to 1992-1994 in Israel. Circulation 1997;95:342-350.
53. Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, et al, for the Participants in the National Registry of Myocardial Infarction. Treatment of myocardial infarction in the United States, 1990-1993: observations from the National Registry of Myocardial Infarction. Circulation 1994;90: 2103-2114.
54. Smith SC Jr, Gilpin E, Ahnve S, Dittrich H, Nicod P, Henning H, Ross J Jr. Outlook after acute myocardial infarction in the very elderly compared with that in patients aged 65 to 75 years. J Am Coll Cardiol 1990;16:784-792.
55. MacMahon S, Collins R, Peto R, Koster RW, Yusuf S. Effects of prophylactic lidocaine in suspected acute myocardial infarction: an overview of results from the randomized, controlled trials. JAMA 1988;260:1910-1916.
56. The Second International Study of Infarct Survival (ISIS-2) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;2:349-360.
57. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR, for the Anglo-Scandinavian Study of Early Thrombolysis (ASSET) Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet 1988;2:525-530.
58. AIMS Trial Study Group. Effects of intravenous APSAC on mortality after acute myocardial infarction: preliminary report of a placebo-controlled clinical trial. Lancet 1988;1:545-549.
59. Gruppo Italiano per lo Studio della Streprochinasi nell'Infarcto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet 1987;2:871-874.
60. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hamptou JR, for the Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Lancet 1990;335:1175-1178.
61. AIMS Trial Study Group. Long term effects of intravenous anistreplase in acute myocardial infarction: final report of the AIMS study. Lancet 1990;335: 427-431.
62. White HD, Barbash CI, Califf RM, Simes RJ, Granger CB, Weaver WD, et al, for the GUSTO-I Investigators. Age and outcome with contemporary thrombolytic therapy. Circulation 1996;94:1826-1833.
63. Newby LK, Rutsch WR, Califf RM, Simoons ML, Aylward PE, Armstrong PW, et al, for the GUSTO I Investigators. Time from symptom onset to treatment and outcomes after thrombolytic therapy. J Am Coll Cardiol 1996; 27:1646-1655.
64. Tresch DD, Brady WJ, Aufderheide TP, Lawrence SW, Williams KJ. Comparison of elderly and younger patients with out-of-hospital chest pain: clinical characteristics, acute myocardial infarction, therapy, and outcomes. Arch Intern Med 1996;156:1089-1093.
65. Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ, for the Participants in the National Registry of Myocardial Infarction. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. Ann Intern Med 1996;124:283-291.
66. Gore JM, Sloan M, Price TR, Randall AM, Bovill H, Collen D, et al. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study: thrombolysis in myocardiol infarction, phase II, pilot and clinical trial. Circulation 1991;83:448-459.
67. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994;343:311-322.
68. Lesnefsky EJ, Lundergan CF, Hodgson JMcB, Nair R, Reiner JS, Greenhouse SW, et al. Increased left ventricular dysfunction in elderly patients despite successful thrombolysis: the GUSTO-I angiographic experience. J Am Coll Cardiol 1996;28:331-337.
69. Maggioni AP, Maseri A, Fresco C, Franzosi MG, Mauri F, Santoro E, Tognoni G, for the Investigators of the Gruppo Italiano per lo Studio della Soprayvivenza nell'Infarto Miocardico (GISSI-2). Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med 1993;329:1442-1448.
70. American College of Cardiology, American Heart Association. Guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Committee on Management of Acute Myocardial Infarction. J Am Coll Cnrdiol 1996;28:1328-1428.
71. Forman DE, Bernal JLG, Wei JY. Management of acute myocardial infarction in the very elderly. Am J Med 1992;93:315-326.
72. Laster SB, Rutherford BD, Giorgi LV, Shimshak TM, McConahay DR, Johnson WJ Jr, et al. Results of direct percutaneous transluminal coronary angioplasty in octogenarians. Am J Cardiol 1996;77:10-13.
73. Weintraub RM, Wei JY, Thurer RL. Surgical repair of remediable postinfarction cardiogenic shock in the elderly: early and long-term results. J Am Geriatr Soc 1986;34:389-392.
74. Daida H, Kottke TE, Backes RJ, Gersh BJ, Tangalos EG, Bailey KR. Arc coronary-care unit changes in therapy associated with improved survival of elderly patients with acute myocardial infarction? Mayo Clin Proc 1997;72: 1014-1021.
75. The First International Study of Infarct Survival (ISIS-1) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 1986;2:57-65
76. Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malck I, Nyberg G, et al. Effect on mortality of metoprolol in acute myocardial infarction: a double blind randomised trial. Lancet 1981;2:823-827.
77. The MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI): a randomised placebo-controlled international trial. Eur Heart J 1985;6:199-226.
78. The International Collaborative Study Group. Reduction of infarct size with early use of timolol in acute myocardial infarction. N Engl J Med 1984;310:9-15.
79. The TIMI Study Group. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) phase II trial. N Engl J Med 1989;320:618-627.
80. Pederson TR, for the Norwegian Multicenter Study Group. Six-year follow-up of the Norwegian multicenter study on timolol after acute myocardial infarction. N Engl J Med 1985;313:1055-1058.
81. Gundersen T, Abrahamsen AM, Kjekshus J, Ronnevik PK, for the Norwegian Multicentre Study Group. Timolol-related reduction in mortality and reinfarction in patients ages 65-75 years surviving acute myocardial infarction. Circulation 1982;66:1179-1184.
82. Beta-Blocker Heart Attack Trial Research Group. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results. JAMA 1982;247:1707-1714.
83. Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. β-Blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med 1992;93:605-610.
84. Soumerai SB, McLaughlin TJ, Spiegelman D, Hertzmark E, Thibault G, Goldman L. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction. JAMA 1997;277:115-121.
85. Held PH, Yusuf S, Furberg CD. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989;299:1187-1192.
86. Krumholz HM, Radford MJ, Ellerbeck HF, Hennen J, Meehan TP, Petrillo M, et al. Aspirin in the treatment of acute myocardial infarction in elderly Medicare beneficiaries: patterns of use and outcomes. Circulation 1995;92:2841-2847.
87. Pfeffer MA, Braunwald E, Moyé LA, Basta H, Brown EJ Jr, Cuddy TE, et al, for the SAVE Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med 1992;327:669-677.
88. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI-3). Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet 1994;343:1115-1122.
89. Second Report of the Sixty-Plus Reinfarction Group. Risk of long-term anticoagulant therapy in elderly patients after myocardial infarction. Lancet 1982; 1:64-68.
90. Smith P, Arnesen H, Abdelnoor M. Effect of long-term anticoagulant therapy in subgroups after acute myocardial infarction. Arch Intern Med 1992;152: 993-997.
91. Convertino V, Hung J, Goldwater D, DeBusk RF. Cardiovascular responses to exercise in middle-aged men after 10 days of bed rest. Circulation 1982;65: 134-140.
92. Ciaroni S, Delonca J, Righetti A. Early exercise testing after acute myocardial infarction in the elderly: clinical evaluation and prognostic significance. Am Heart J 1993;126:304-311.
93. Maggioni AP, Turazza FM, Tavazzi L. Risk evaluation using exercise testing in elderly patients after acute myocardial infarction. Cardiol Elderly 1995;3:88-93.
94. Nicod P, Gilpin H, Dittrich H, Polikar R, Hjalmarson A, Blacky R, et al. Short-and long-term clinical outcome after Q wave and non-Q-wave myocardial infarction in a large patient population. Circulation 1989;79:528-536.
95. Camerieri A, Picano H, Landi P, Michelassi C, Pingitore A, Minardi G, et al, for the Echo Persantine Italian Cooperative (EPIC) Study Group. Prognostic value of dipyridamole echocardiography early after myocardial infarction in elderly patients. J Am Coll Cardiol 1993;22:1809-1815.
96. Chung MK, Bosner MS, McKenzie JP, Shen J, Rich MW. Prognosis of patients ≥70 years of age with non-Q-wave acute myocardial infarction compared with younger patients with similar infarcts and with patients ≥70 years of age with Q-wave acute myocardial infarction. Am J Cardiol 1995;75:18-22.
97. Tervahauta M, Pekkanen J, Nissinen A. Risk factors of coronary heart disease and total mortality among elderly men with and without preexisting coronary heart disease: the Finnish Cohorts of the Seven Countries Study. J Am Coll Cardiol 1995;26:1623-1629.
98. The Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-3025.
99. Carlson LA, Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand 1988;223:405-418.
100. Hermanson B, Omenn GS, Kronmal RA, Gersh BJ, and Participants in the Coronary Artery Surgery Study (CASS). Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease: results from the CASS Registry. N Engl J Med 1988;319:1365-1369.
101. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann Intern Med 1992;117:1003-1009.
102. Alpert JS. Nitrate therapy in the elderly. Am J Cardiol 1990;65:23J-27J.
103. Antiplatelet Trialists' Collaboration. Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 1988;296:320-331.
104. Echt DS, Liebson PR, Mitchell LB, Peters RW, Obias-Manno D, Barker AH, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo: the Cardiac Arrhythmia Suppression Trial. N Engl J Med 1991;324: 781-788.
105. Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W, et al. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J 1989;117:543-549.
106. Wenger NK. Populations with special needs for exercise rehabilitation: elderly coronary patients. In: Wenger NK, Hellerstein HK, eds. Rehabilitation of the Coronary Patient. Third edition. New York: Churchill Livingstone, 1992; 415-420.
107. Wenger NK, Froelicher ES, Smith LK, Ades PA, Berra K, Blumenthal JA, et al. Cardiac Rehabilitation. Clinical Practice Guideline number 17, AHCPR Publication no. 96-0672. Rockville, MD: United States Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research and the National Heart, Lung, and Blood Institute, 1995.
108. Lavic CJ, Milani RV. Benefits of cardiac rehabilitation and exercise training in elderly women. Am J Cardiol 1997;79:664-666.
109. Pollock ML, Carroll JH, Graves JE, Leggett SH, Braith RW, Limacher M, Hagberg JM. Injuries and adherence to walk/jog and resistance training programs in the elderly. Med Sci Sports Exerc 1991;23:1194-1200.
110. Lavic CJ, Milani RV. Effects of cardiac rehabilitation programs on exercise capacity, coronary risk factors, behavioral characteristics, and quality of life in a large elderly cohort. Am J Cardiol 1995;76:177-179.
111. Ades PA, Grunvald MH. Cardiopulmonary exercise testing before and after conditioning in older coronary patients. Am Heart J 1990;120:585-589.
112. Ades PA, Waldmann ML, Poehlman ET, Gray P, Horton ED, Horton ES, LeWinter MM. Exercise conditioning in older coronary patients: submaximal lactate response and endurance capacity. Circulation 1993;88:572-577.
113. Peterson ED, Cowper PA, Jollis JG, Bebchuk JD, DeLong ER, Muhlbaier LH, et al. Outcomes of coronary artery bypass graft surgery in 24 461 patients aged 80 years or older. Circulation 1995;92(suppl II):85-91.
114. Jonsson A, Agnarsson BA, Hallgrimsson J. Coronary atherosclerosis and myocardial infarction in nonagenarians: a retrospective autopsy study. Age Ageing 1985;14:109-112.
115. Weintraub WS, Clements SD, Ware J, Craver IM, Cohen CL, Guyton RA. Coronary artery surgery in octogenarians. Am J Cardiol 1991;68:1530-1534.
116. Glower DD, Christopher TD, Milano CA, White WD, Smith LR, Jones RH, Sabiston DC Jr. Performance status and outcome after coronary artery bypass grafting in persons aged 80 to 93 years. Am J Cardiol 1992;70:567-571.
117. Ko W, Gold JP, Lazzaro R, Zelano JA, Lang S, Isom W, Krieger KH. Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment. Circulation 1992;86(suppl II):191-197.
118. Tsai TP, Denton TA, Chaux A, Matloff JM, Kass RM, Blanche C, Khan SS. Results of coronary artery bypass grafting and/or aortic or mitral valve operation in patients ≥90 years of age. Am J Cardiol 1994;74:960-962.
119. Gersh BJ, Kronmal RA, Schaff HV, Frye RL, Ryan TJ, Myers WO, et al. Long-term (5-year) results of coronary bypass surgery in patients 65 years or older: a report from the Coronary Artery Surgery Study. Circulation 1983;68 (suppl II): 190-199.
120. Barzilay JI, Kronmal RA, Bittner V, Eaker E, Evans C, Foster ED. Coronary artery disease and coronary artery bypass grafting in diabetic patients aged ≥65 years: report from the Coronary Artery Surgery Study (CASS) Registry. Am J Cardiol 1994;74:334-339.
121. Noyez L, van der Werf T, Remmen GHJ, Kaan GL, Lacquet LK. Importance of the internal mammary artery for coronary bypass grafting in patients aged ≥70 years. Am J Cardiol 1995;75:734-736.
122. Naunheim KS, Dean PA, Fiore AC, McBride LR, Pennington DG Kaiser GC, et al. Cardiac surgery in the octogenarian. Eur J Cardiothorac Surg 1990;4: 130-135.
123. Katz ES, Tunick PA, Rusinek H, Ribakove G, Spencer FC, Kronzon I. Protruding aortic atheromas predict stroke in elderly patients undergoing cardiopulmonary bypass: experience with intraoperative transesophageal echocardiography. J Am Coll Cardiol 1992;20:70-77.
124. Newman ME, Croughwell ND, Blumenthal JA, White WD, Lewis JB, Smith LR, et al. Effect of aging on cerebral autoregulation during cardiopulmonary bypass: association with postoperative cognitive dysfunction. Circulation 1994;90(suppl III):243-249.
125. Jaeger AA, Hlatky MA, Paul SM, Gortner SR. Functional capacity after cardiac surgery in elderly patients. J Am Coll Cardiol 1994;24:104-108.
126. Gersh BJ, Kronmal RA, Schaff HV, Erye RL, Ryan TJ, Mock MB, et al, and the Participants in the Coronary Artery Surgery Study (CASS). Comparison of coronary artery surgery and medical therapy in patients 65 years of age or older: a nonrandomized study from CASS registry. N Engl J Med 1985;313:217-222.
127. Freeman WK, Schaff HV, O'Brien PC, Orszulak TA, Naessens JM, Tajik AJ. Cardiac surgery in the octogenarian: perioperative outcome and clinical follow-up. J Am Coll Cardiol 1991;18:29-35.
128. Horvath KA, DiSesa VJ, Peigh PS, Couper GS, Collins JJ Jr, Cohn LH. Favorable results of coronary artery bypass grafting in patients older than 75 years. J Thorac Cardiovasc Surg 1990;99:92-96.
129. Jeroudi MO, Kleiman NS, Minor ST, Hess KR, Lewis JM, Winters WL Jr, Raizner AE. Percutaneous transluminal coronary angioplasty in octogenarians. Ann Intern Med 1990;113:423-428.
130. Kelsey SF, Miller DP, Holubkov R, Lu AS, Cowley AU, Faxon DP, Detre KM, and Investigators from the NHLBI PTCA Registry. Results of percutaneous transluminal coronary angioplasty in patients ≥65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry). Am J Cardiol 1990;66:1033-1038.
131. Bedotto JB, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Shimshak TM, et al. Results of multivessel percutaneous transluminal coronary angioplasty in persons aged 65 years and older. Am J Cardiol 1991;67:1051-1055.
132. Jackman JD Jr, Navetta FI, Smith JE, Tcheng JE, Davidson CJ, Phillips HR, et al. Percutaneous transluminal coronary angioplasty in octogenarians as an effective therapy for angina pectoris. Am J Cardiol 1991;68:116-119.
133. ten Berg JM, Voors AA, Suttorp MJ, Ernst MPG, Mast EG, Bal E, Plokker HWT. Long-term results after successful percutaneous transluminal coronary angioplasty in patients over 75 years of age. Am J Cardiol 1996;77:690-695.
134. Tan KH, Sulke N, Taub N, Karani S, Sowton E. Percutaneous transluminal coronary angioplasty in patients 70 years of age or older: 12 years' experience. Br Heart J 1995;74:310-317.
135. Thompson RC, Holmes DR Jr, Grill DE, Mock MB, Bailey KR. Changing outcome of angioplasty in the elderly. J Am Coll Cardiol 1996;27:8-14.
136. Macaya C, Alfonso F, Iniguez A, Zarco P. Long-term clinical and angiographic follow-up of percutaneous transluminal coronary angioplasty in patients ≥65 years of age. Am J Cardiol 1990;66:1513-1515.
137. Thompson RC, Holmes DR Jr, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. J Am Coll Cardiol 1991;17:1245-1250.
138. Weyrens FJ, Goldenberg I, Mooney JF, Holmes DR, O'Keefe J, Myler RK, et al. Percutaneous transluminal coronary angioplasty in patients aged ≥90 years. Am J Cardiol 1994;74:397-398.
139. O'Keefe JH Jr, Sutton MB, McCallister BD, Vacek JL, Piehler JM, Ligon RW, Hartzler GO. Coronary angioplasty versus bypass surgery in patients >70 years old matched for ventricular function. J Am Coll Cardiol 1994;24:425-430.
140. Morrison DA, Bies RD, Sacks J. Coronary angioplasty for elderly patients with "high risk" unstable angina: short-term outcomes and long-term survival. J Am Coll Cardiol 1997;29:339-344.
141. Popma JJ, Satler LF, Mintz GS, Hong MK, Kent KM, Pichard AD, Leon MB. Coronary angioplasty and new device therapy. Cardiol Elderly 1993;1:62-70.
142. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994;23:275-285.
143. Lipsitz LA. Orthostatic hypotension in the elderly. N Engl J Med 1989;321: 952-956.
144. Bots ML, Witteman JCM, Hofman A, de Jong PTVM, Grobbee DE. Low diastolic blood pressure and atherosclerosis in elderly subjects: the Rotterdam Study. Arch Intern Med 1996;156:843-848.
145. Staessen J, Amery A, Fagard R. Editorial review: isolated systolic hypertension in the elderly. J Hypertens 1990;8:393-405.
146. Pasierski T, Pearson AC, Labovitz AJ. Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights. Am Heart J 1991;122:528-534.
147. Reaven PD, Barrett-Connor E, Edelstein S. Relation between leisure-time physical activity and blood pressure in older women. Circulation 1991;83: 559-565.
148. Veterans Administration Cooperative Study Group on Antihypertensive Agents. Effects of treatment on morbidity in hypertension. III. Influence of age, diastolic pressure, and previous cardiovascular disease: further analysis of side effects. Circulation 1972;45:991-1004.
149. Apple-gate WB. Hypertension in elderly patients. Ann Intern Med 1989;110: 901-915.
150. Amery A, Birkenhäger W, Brixko R, Bulpitt C, Clement D, Deruyttere M, et al. Efficacy of antihypertensive drug treatment according to age, sex, blood pressure, and previous cardiovascular disease in patients over the age of 60. Lancet 1986;2:589-592.
151. Sagie A, Benjamin EJ, Galderisi M, Larson MG, Evans JC, Fuller DL, et al. Echocardiographic assessment of left ventricular structure and diastolic filling in elderly subjects with borderline isolated systolic hypertension (the Framingham Heart Study). Am J Cardiol 1993;72:662-665.
152. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-Up Program. II. Mortality by race, sex, and age. JAMA 1979;242:2572-2577.
153. Amery A, Birkenhäger W, Brixko P, Bulpitt C, Clement D, Deruyttere, et al. Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial. Lancet 1985;1:1349-1354.
154. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
155. Messerli FH, Ventura HO, Amodeo C. Osler's maneuver and pseudohypertension. N Engl J Med 1985;312:1548-1551.
156. Applegate WB, Miller ST, Elam JT, Cushman WC, El Derwi D, Brewer A, Graney MJ. Nonpharmacologic intervention to reduce blood pressure in older patients with mild hypertension. Arch Intern Med 1992;152:1162-1166.
157. Whelton PK, Appel LJ, Espeland MA, Applegate WR, Ettinger WH Jr, Kostis JB, et al, for the TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled Trial of Nonpharmacologic Interventions in the Elderly (TONE). JAMA 1998;279:839-846.
158. Johnson AG, Nguyen TV, Day RO. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994;121:289-300.
159. Gurwitz JH, Everitt DE, Monane M, Glynn RJ, Choodnovskiy I, Beaudet MP, Avorn J. The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrocholorothiazide in elderly persons. J Gerontol A Biol Sci Med Sci 1996;51A:M74-M79.
160. Staessen J, Fagard R, Lijnen P, Van Hoof R, Amery A. Review of the major hypertension trials in the elderly. Cardiovasc Drugs Ther 1991;4(suppl 6): 1237-1247.
161. Coope J, Warrender TS. Randomized trial of treatment of hypertension in the elderly patient in primary care. Br Med J 1986;293:1145-1151.
162. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991; 265:3255-3264.
163. Kostis JB, Davis BR, Cutler J, Grimm RH Jr, Berge KG, Cohen JD, et al, for the SHEP Cooperative Research Group. Prevention of heart failure by antihypertensive drug treatment in older persons witn isolated systolic hypertension. JAMA 1997;278:212-216.
164. Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, et al, for the Systolic Hypertension in the Elderly Program Cooperative Research Group. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. JAMA 1996;276:1886-1892.
165. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, et al, for the SHEP Cooperative Research Group. Change in depression as a precursor of cardiovascular events. Arch Intern Med 1996;156:553-561.
166. Mulrow CD, Cornell JA, Herrera CR, Kadri A, Farnett L, Aguilar C. Hypertension in the elderly: implications and generalizability of randomized trials. JAMA 1994;272:1932-1938.
167. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertension 1993;15:967-978.
168. Applegate WB, Phillips HL, Schnaper H, Shepherd AMM, Schocken D, Luhr JC, et al. A randomized controlled trial of the effects of three antihypertensive agents on blood pressure control and quality of life in older women. Arch Intern Med 1991;151:1817-1823.
169. Perry HM, Hall WD, Benz JR, Bartels DW, Kostis JB, Townsend RR, et al. Efficacy and safety of atenulol, enalapril, and isradipine in elderly hypertensive women. Am J Med 1994;96:77-86.
170. Pahor M, Guralnik JM, Furberg CD, Carbonin P, Havlik RJ. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet 1996;347:1061-1065.
171. Amery A, Birkenhäger W, Bulpitt C. Influence of antihypertensive therapy on serum cholesterol in elderly hypertensive patients. Acta Cardiol 1982;37:235-244.
172. Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman N. Antihypertensive drug side effects in the Hypertension Detection and Follow-up Program. Hypertension 1988;11(suppl II):51-55.
173. Amery A, Birkenhager W, Bulpitt C, Clement D, de Leeuw P, Deruyttere ML, et al. Diuretics: a risk in the long-term treatment of hypertensive patients? J Hypertens 1988;6:125-130.
174. Sugiura M, Matsushita S, Ueda K. A clinicopathological study on valvular diseases in 3,000 consecutive autopsies of the aged. Jpn Circ J 1982;46:337-345.
175. Lindroos M, Kupari M, Heikkilä J, Tilvis R. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-1225.
176. Culliford AT, Galloway AC, Colvin SB, Grossi EA, Baumann G, Esposito R, et al. Aortic valve replacement for aortic stenosis in persons aged 80 years and over. Am J Cardiol 1991;67:1256-1260.
177. Iivanainen AM, Lindroos M, Tilvis R, Heikkilä J, Kupari M. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996;78: 97-101.
178. Lund O, Nielsen TT, Magnussen K, Pilegaard HK, Knudsen MA. Valve replacement for calcified aortic stenosis in septuagenarians infers normal life-length. Scand J Cardiovasc Surg 1991;25:37-44.
179. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988;9(suppl E):57-64.
180. Turina J, Hess O, Sepuleri F, Krayenbuehl HP. Spontaneous course of aortic valve disease. Eur Heart J 1987;8:471-483.
181. Elayda MacA A, Hall RJ, Reul RM, Alonzo DM, Gillette N, Reul GJ Jr, Cooley DA. Aortic valve replacement in patients 80 years and older: operative risks and long-term results. Circulation 1993;88(part 2):11-16.
182. Aranki SF, Rizzo RJ, Couper GS, Adams DH, Collins JJ Jr, Gildea JS, et al. Aortic valve replacement in the elderly: effect of gender and coronary artery disease on operative mortality. Circulation 1993;88(part 2): 17-23.
183. Craver JM, Weintraub WS, Jones EL, Guyton KA, Hatcher CR Jr. Predictors of mortality, complications, and length of stay in aortic valve replacement for aortic stenosis. Circulation 1988;78(suppl I):85-90.
184. Rodriguez AR, Kleiman NS, Minor ST, Zoghbi WA, West MS, DeFelice CA, et al. Factors influencing the outcome of balloon aortic valvuloplasty in the elderly. Am Heart J 1990;120:373-380.
185. McKay CR, Waller BF. Current status of balloon valvuloplasty. Cardiol Elderly 1993;1:77-85.
186. O'Neill WW, for the Mansfield Scientific Aortic Valvuloplasty Registry Investigators. Predictors of long-term survival after percutaneous aortic valvuloplasty: report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. J Am Coll Cardiol 1991;17:193-198.
187. Cheitlin MD. Valve disease in the octogenarian. In: Wenger NK, ed. Cardiovascular Disease in the Octogenarian and Beyond. London: Martin Dunitz Publishers, 1999:255-266.
188. Scognamiglio R, Rahimtoola SH, Fasoli G, Nistri S, Volta SD. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994;331:689-694.
189. Le Feuvre C, Bonan R, Lachurie M-L, Leclerc Y, Petitclerc R, Dyrda I, Crépeau J: Balloon mitral commissurotomy in patients aged ≥70 years. Am J Cardiol 1993;71:233-236.
190. Ofili EO, Rich MW, Brown P, Lewis J. Safety and usefulness of transesophageal echocardiography in persons aged ≥70 years. Am J Cardiol 1990;66: 1279-1280.
191. Nair CK, Biddle P, Kaneshige A, Cook C, Ryschon K, Sketch MH Sr. Ten-year experience with mitral valve replacement in the elderly. Am Heart J 1992;124: 154-159.
192. Bolling SK, Deeb M, Bach DS. Mitral valve reconstruction in elderly, ischemic patients. Chest 1996;109:35-40.
193. Dajani AS, Taubert KA, Wilson W, Bolger AF, Bayer A, Ferrieri P, et al. Prevention of bacterial endocarditis: recommendations by the American Heart Association. JAMA 1997;277:1794-1801.
194. Terpenning MS, Buggy BP, Kauffman CA. Infective endocarditis: clinical features in young and elderly patients. Am J Med 1987;83:626-634.
195. Selton-Suty C, Hoen B, Grentzinget A, Houplon P, Maignan M, Juillière Y, et al. Clinical and bacteriological characteristics of infective endocarditis in the elderly. Heart 1997;77:260-263.
196. Werner GS, Schulz R, Fuchs JB, Andreas S, Prange H, Ruschewski W, Kreuzer H. Infective endocarditis in the elderly in the era of transesophageal echocardiography: clinical features and prognosis compared with younger patients. Am J Med 1996;100:90-97.
197. Kearney RA, Eisen HJ, Wolf JE. Nonvalvular infections of the cardiovascular system. Ann Intern Med 1994;121:219-230.
198. Fay WP, Taliercio CP, Ilstrup DM, Tajik AJ, Gersh BJ. Natural history of hypertrophic cardiomyopathy in the elderly. J Am Coll Cardiol 1990;16:821-826.
199. Lever HM, Karam RF, Currie PJ, Healy BJ. Hypertrophic cardiomyopathy in the elderly: distinctions from the young based on cardiac shape. Circulation 1989;79:580-589.
200. Pearson AC, Gudipati CV, Labovitz AJ. Systolic and diastolic flow abnormalities in elderly patients with hypertensive hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;12:989-995.
201. Lewis JF, Maron BJ. Clinical and morphologic expression of hypertrophic cardiomyopathy in patients ≥65 years of age. Am J Cardiol 1994;73:1105-1111.
202. Koch J-P, Maron BJ, Epstein SE, Morrow AG. Results of operation for obstructive hypertrophic cardiomyopathy in the elderly: septal myotomy and myectomy in 20 patients 65 years of age or older. Am J Cardiol 1980;46:963-966.
203. Coughlin SS, Tefft MC, Rice JC, Gerone JL, Baughman KL. Epidemiology of idiopathic dilated cardiomyopathy in the elderly: pooled results from two case-control studies. Am J Epidemiol 1996;143:881-888.
204. Burrows B, Alpert JS, Ross JC, for the 18th Bethesda Conference. Cardiovascular disease in the elderly: pulmonary heart disease. J Am Coll Cardiol 1987; 10(suppl A):63A-65A.
205. Braman SS, Eby E, Kuhn C, Rounds S. Primary pulmonary hypertension in the elderly. Arch Intern Med 1991;151:2433-2438.
206. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med 1994;154:861-866.
207. Stein PD, Gottschalk A, Saltzman HA, Terrin ML. Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol 1991;18:1452-1457.
208. Siddique RM, Siddique MI, Connors AF Jr, Rimm AA. Thirty-day case-fatality rates for pulmonary embolism in the elderly. Arch Intern Med 1996;156: 2343-2347.
209. Konstam MA, Dracup K, Baker DW, Bottorff MB, Brooks NH, Dacey RA, et al. Heart failure: Evaluation and Care of Patients with Left-Ventricular Systalic Dysfunction. Clinical Practice Guideline no. 11. AHCPR Publication no. 94-0612. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, United States Department of Health and Human Services, 1994.
210. Committee on Evaluation and Management of Heart Failure. Guidelines for the evaluation and management of heart failure: report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 1995;92:2764-2784.
211. McKee PA, Castelli WP, McNamara PM, Kannel WB. The natural history of congestive heart failure: the Framingham Study. N Engl J Med 1971;285: 1441-1446.
212. Rich MW, Shah AS, Vinson JM, Freedland KE, Kuru T, Sperry JC. Iatrogenic congestive heart failure in older adults: clinical course and prognosis. J Am Geriatr Soc 1996;44:638-643.
213. Wenger NK, Franciosa JA, Weber KT for the 18th Bethesda Conference. Cardiovascular disease in the elderly: heart failure. J Am Coll Cardiol 1987; 10(suppl A):73A-76A.
214. Wong VVF, Gold S, Fukuyama O, Blanchette PL. Diastolic dysfunction in elderly patients with congestive heart failure. Am J Cardiol 1989;63:1526-1528.
215. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316:1429-1435.
216. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302.
217. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325:303-310.
218. Chapman D, Wang T, Gheorghiade M. Therapeutic approaches to heart failure in elderly patients. Cardiol Elderly 1994;2:89-97.
219. Wenger NK. Populations with special needs for exercise rehabilitation: patients with left ventricular dysfunction and congestive heart failure. In: Wenger NK, Hellerstein HK, eds. Rehabilitation of the Coronary Patient. Third edition. New York: Churchill Livingstone, 1992;403-413.
220. Bittner V, Weiner DH, Yusuf S, Rogers WJ, McIntyre KM, Bangdiwala SI, et al, for the SOLVD Investigators. Prediction of mortality and morbidity with a 6-minute walk test in patients with left ventricular dysfunction. JAMA 1993; 270:1702-1707.
221. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 314:1547-1552.
222. De Bock V, Mets T, Romagnoli M, Derde MP. Captopril treatment of chronic heart failure in the very old. J Gerontol 1994;49:M148-M152.
223. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, et al, for the Evaluation of Losartan in the Elderly (ELITE) Study Investigators. Randomised trial of losartan versus captopril in patients over 65 with heart failure. Lancet 1997;349:747-752.
224. Gheorghiade M, St. Clair J, St. Clair C, Beller GA. Hemodynamic effects of intravenous digoxin in patients with severe heart failure initially treated with diuretics and vasodilators. J Am Coll Cardiol 1987;9:849-857.
225. Ware JA, Snow E, Luchi JM, Luchi RJ. Effect of digoxin on ejection fraction in elderly patients with congestive heart failure. J Am Geriatr Soc 1984;32: 631-635.
226. Packer M, Gheorghiade M, Young JB, Costantini PJ, Adams KE, Cody RJ, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
227. Marcus FI. Pharmacokinetic interactions between digoxin and other drugs. J Am Coll Cardiol 1985;5:82A-90A.
228. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
229. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med 1996;101:270-276.
230. Kornowski R, Zeeli D, Averbuch M, Finkelstein A, Schwartz D, Moshkovitz M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J 1995;129:762-766.
231. Krumholz HM, Butler I, Miller J, Vaccarino V, Williams CS, de Leon CFM, et al. Prognostic importance of emotional support for elderly patients hospitalized with heart failure. Circulation 1998;97:958-964.
232. Kobashigawa JA. Early and late complications in the elderly heart transplant recipient. Cardiol Elderly 1996;4:15-21.
233. Martin A, Benbow LJ, Butrous GS, Leach C, Camm AJ. Five-year follow-up of 101 elderly subjects by means of long-term ambulatory cardiac monitoring. Eur Heart J 1984;5:592-596.
234. Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Prevalence of atrial fibrillation in elderly subjects. Am J Cardiol 1994;74:236-241.
235. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982;81:302-307.
236. Kantelip JP, Sage E, Duchene-Marulla ZP. Findings on ambulatory electrocardiographie monitoring in subjects older than 80 years. Am J Cardiol 1986; 57:398-401.
237. Lipsitz LA. Syncope in the elderly. Ann Intern Med 1983;90:92-105.
238. Frishman WH, Heiman M, Karpenos A, Ooi WL, Mitzner A, Goldkorn R, Greenberg S for the Bronx Longitudinal Aging Study. Twenty-four-hour ambulatory electrocardiography in elderly subjects: prevalence of various arrhythmias and prognostic implications. Am Heart J 1996;132:297-302.
239. Ingerslev J, Bjerregaard P. Prevalence and prognostic significance of cardiac arrhythmias detected by ambulatory electrocardiography in subjects 85 years of age. Eur Heart J 1986;7:570-575.
240. Josephson RA, Papa LA, Brooks MM, Morris M, Akiyama T, Greene HL, for the CAST Investigators. Effect of age on postmyocardial infarction ventricular arrhythmias (Holter registry data from CAST I and CAST II). Am J Cardiol 1995;76:710-713.
241. Mercando AD, Aronow WS, Epstein S, Fishbach M. Signal-averaged electrocardiography and ventricular tachycardia as predictors of mortality after acute myocardial infarction in elderly patients. Am J Cardiol 1995;76:436-440.
242. Aronow WS, Mercando AD, Epstein S, Kronzon I. Effect of quinidine or procainamide versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in elderly patients with heart disease and complex ventricular arrhythmias. Am J Cardiol 1990;66:423-428.
243. Manolio TA, Furberg CD, Rautaharju PM, Siscovick D, Newman AB, Borhani NO et al, for the Cardiovascular Health Study (CHS) Collaborative Research Group. Cardiac arrhythmias on 24-h ambulatory electrocardiography in older women and men. J Am Call Cardiol 1994;23:916-925.
244. Epstein LM, Chiesa N, Wong MN, Lee RJ, Griffin JC, Scheinman MM, Lesh MD. Radiofrequency catheter ablation in the treatment of supraventricular tachycardia in the elderly. J Am Coll Cardiol 1994;23:1356-1362.
245. Tresch DD, Troup PJ, Thakur RK, Veseth-Rogers J, Tucker V, Wetherbec JN, et al. Comparison of efficacy of automatic implantable cardioverter defibrillator in patients older and younger than 65 years of age. Am J Med 1991;90:717-724.
246. Carlsson J, Tebbe U, Rox I, Harmjanz D, Haerten K, Neuhaus K-L, et al, for the ALKK-Study Group. Cardioversion of atrial fibrillation in the elderly. Am J Cardiol 1996;78:1380-1384.
247. McCrory DC, Matchar DB, Samsa G, Sanders LL, Pritchett ELC. Physician attitudes about anticoagulation for nonvalvular atrial fibrillation in the elderly. Arch Intern Med 1995;155:277-281.
248. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study. Arch Intern Med 1987;147: 1561-1564.
249. Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation: the Copenhagen AFASAK study. Lancet 1987;1:175-179.
250. The Stroke Prevention in Atrial Fibrillation Investigators. Stroke prevention in atrial fibrillation study: final results. Circulation 1991;84:527-539.
251. Shen W-K, Haves DL. Pacing the octogenarians and nonagenarians: should age be a consideration for pacing and outcome analysis of pacing in the very elderly? Cardiol Elderly 1994;2:161-170.
252. Shen W-K, Haves DL, Hammill SC, Bailey KR, Ballard DJ, Gersh BJ. Survival and functional independence after implantation of a permanent pacemaker in octogenarians and nonagenarians: a population-based study. Ann Intern Med 1996;125:476-480.
253. Channon KM, Hargreaves MR, Cripps TR, Gardner M, Ormcrod OJ. DDD vs VVI pacing in patients aged over 75 years with complete heart block: a double-blind crossover comparison. Q J Med 1994;87:245-251.
254. Lamas GA, Pashos CL, Normand S-LT, McNeil B. Permanent pacemaker selection and subsequent survival in elderly Medicare pacemaker recipients. Circulation 1995;91:1063-1069.
255. Dreifus LS, Fisch C, Griffin JC, Gillette PC, Mason JW, Parsonnet V. Guidelines tor implantation of cardiac pacemakers and antiarrhythmias devices: a report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures, Committee on Pacemaker Implantation. J Am Coll Cardiol 1991;1: 1-13.
256. Panotopoulos PT, Axtell K, Anderson AJ, Sra J, Blanck Z, Deshpande S, et al. Efficacy of the implantable cardioverter defibrillator in the elderly. J Am Coll Cardiol 1997;29:556-560.
257. Tresch DD. CPR in the elderly: when should it be performed? Geriatrics 1991;46:47-56.
258. Podrazik PM, Schwartz JB. Principles of cardiovascular pharmacology at advanced age. In: Wenger NK, ed. Cardiovascular Disease in the Octogenarian and Beyond. London: Martin Dunitz Publishers, 1999:127-139.
259. Lavarenne J, Dumas R, Cayrol C. Effets indésirables des médicaments chez les personnes âgées. Bilan des observation recueilliés pendant un an par l'Association Française des Centres de Pharmacovigilance. Therapic 1983;38: 485-493.
260. Warren JL, McBean AM, Mass SL, Babish JD. Hospitalizations with adverse events caused by digitalis therapy among elderly Medicare beneficiaries. Arch Intern Med 1994;154:1482-1487.
261. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88-90.
262. World Health Organization Study Group. Epidemiology and Prevention of Cardiovascular Disease in Elderly People. WHO Technical Report Series 853. Geneva, World Health Organization, 1995.
263. The Clinical Quality Improvement Network (CQIN) Investigators. Low incidence of assessment and modification of risk factors in acute care patients at high risk for cardiovascular events, particularly among females and the elderly. Am J Cardiol 1995;76:570-573.
264. Masaki KH, Petrovitch H, Rodriguez BL, Curb JD. The value of risk factor modification in old age. Cardiol Elderly 1993;1:391-397.
265. Weijenberg MP, Feskens EJM, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up: the Zutphen Elderly Study. Am J Epidemiol 1996;143: 151-158.
266. Jajieh CL, Ostfeld AM, Freeman DH Jr. Smoking and coronary heart disease mortality in the elderly. JAMA 1984;252:2831-2834.
267. LaCroix AZ, Lang J, Scherr P, Wallace RB, Cornoni-Huntley J, Berkman L, et al. Smoking and mortality among older men and women in three communities. N Engl J Med 1991;324:1619-1625.
268. Kuller L, Borhani N, Furberg C, Gardin J, Manolio T, O'Leary D, et al. Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study. Am J Epidemiol 1994;139:1164-1179.
269. Fried LP, Kronmal RA, Newman AB, Bild DL, Mittelmark MB, Polak JF, et al, for the Cardiovascular Health Study Collaborative Research Group. Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA 1998;279:585-592.
270. Corti M-C, Guralnik JM, Salive ME, Harris T, Ferrucci L, Glynn RJ, Havlik RJ. Clarifying the direct relation between total cholesterol levels and death from coronary heart disease in older persons. Ann Intern Med 1997;126:753-760.
271. Denke MA, Grundy SM. Hypercholesterolemia in elderly persons: resolving the treatment dilemma. Ann Intern Med 1990;112:780-792.
272. Pacala JT, McBride PE, Grady SL. Management of older adults with hypercholesterolaemia. Drugs Aging 1994;4:366-378.
273. Santinga JT, Rosman HS, Rubenfire M, Maciejko JJ, Kobylak L, McGovern ME, Bruce B. Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemia. Am J Med 1994;96:509-515.
274. Hulley SB, Newman TB. Cholesterol in the elderly: is it important? JAMA 1994;272:1372-1374.
275. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
276. Manolio TA, Furberg CD, Shemanski L, Psaty BM, O'Leary DH, Tracy RP, Bush TL, for the CHS Collaborative Research Group. Associations of post-menopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation 1993;88(part 1):2163-2171.
277. Paffenbarger RS Jr, Hyde RT, Wing AL, Hsieh C-C. Physical activity, all-cause mortality, and longevity of college alumni. N Engl J Med 1986;314:605-613.
278. Braith RW, Pollock ML, Lowenthal DT, Graves JE, Limacher MC. Moderate and high-intensity exercise lowers blood pressure in normotensive subjects 60 to 79 years of age. Am J Cardiol 1994;73:1124-1128.
279. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993;342:1007-1011.
280. Schauffler HH, D'Agostino RB, Kannel WB. Risk For cardiovascular disease in the elderly and associated Medicare costs: the Framingham Study. Am J Prev Med 1993;9:146-154.
281. Wenger NK. Physical inactivity and coronary heart disease in elderly patients. Clin Geriatr Med 1996;12:79-88.
282. Fiatarone MA, O'Neill EF, Ryan ND, Clements KM, Solares GR, Nelson ME, et al. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med 1994;330:1769-1775.
283. American College of Cardiology/American Heart Associaton Task Force on Practice Guidelines Committee on Perioperative Cardiovascular Evaluation for Noncardiac Surgery. Guidelines for perioperative cardiovascular evaluation for noncardiac surgery. Circulation 1996;93:1278-1317.
284. Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol 1991;18:203-214.
285. Towne JB, Weiss DG, Hobson RW II. First phase report of cooperative Veterans Administration asymptomatic carotid stenosis study: operative morbidity and mortality. J Vasc Surg 1990;11:252-259.
286. Wasserman K. Preoperative evaluation of cardiovascular reserve in the elderly. Chest 1993;104:663-664.
287. Mangano DT. Perioperative cardiac morbidity. Anesthesiology 1990;72:153-184.
288. Foster ED, Davis KB, Carpenter JA, Abele S, Fray D. Risk of noncardiac operation in patients with defined coronary disease: the Coronary Artery Surgery Study (CASS) Registry experience. Ann Thorac Surg 1986;41:42-50.
289. Haupt BJ. Utilization of shortstay hospitals: annual summary for the United States, 1978. In: Vital and Health Statistics, Series 13, no. 46. DHEW Publication no. PHS 80-1797. Hyattsville, AID: Office of Health Research, Statistics and Technology, National Center for Health Statistics, 1980.
290. Gerson LW, Skvarch L. Emergency medical service utilization by the elderly. Ann Emerg Med 1982;11:610-612
291. Riley G, Lubitz J, Prihoda R, Rabey E. The use and costs of Medicare services by cause of death. Inquiry 1987;24:233-244.
292. Feller BA. Americans Needing Help to Function at Home. Publication no. 92. Washington, DC: United States Department of Health and Human Services, National Center for Health Statistics, 1983.
293. Heller TA, Larson EB, LoGerfo JP. Quality of ambulatory care of the elderly: an analysis of five conditions. J Am Geriatr Soc 1984;32:782-788.